Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis

Edoardo Del Poggetto,I-Lin Ho,Chiara Balestrieri,Er-Yen Yen,Shaojun Zhang,Francesca Citron,Rutvi Shah,Denise Corti,Giuseppe R Diaferia,Chieh-Yuan Li,Sara Loponte,Federica Carbone,Yoku Hayakawa,Giovanni Valenti,Shan Jiang,Luigi Sapio,Hong Jiang,Prasenjit Dey,Sisi Gao,Angela K Deem,Stefan Rose-John,Wantong Yao,Haoqiang Ying,Andrew D Rhim,Giannicola Genovese,Timothy P Heffernan,Anirban Maitra,Timothy C Wang,Linghua Wang,Giulio F Draetta,Alessandro Carugo,Gioacchino Natoli,Andrea Viale,Giuseppe R. Diaferia,Angela K. Deem,Andrew D. Rhim,Timothy P. Heffernan,Timothy C. Wang,Giulio F. Draetta

DOI: https://doi.org/10.1126/science.abj0486

IF: 56.9

2021-09-17

Science

Abstract:Defining tumor cell immune evasion Mouse models used to study cancer often lack a full immune system, allowing implantation of human tumors into the mice. By contrast, naturally evolving tumors must contend with a fully functional immune system and its destruction of some of the cells (see the Perspective by Ho and Wood). Two groups now report studies on mouse models with a fully intact immune system. Martin et al . started with preexisting murine tumor cell lines and examined their continued evolution in vivo, whereas Del Poggetto et al . examined the development of new pancreatic tumors in the context of inflammation, as is often seen in human patients. In each study, the authors found that the immune system exerted a selective pressure on cells that would give rise to tumors, promoting the survival of those that had lost expression of tumor suppressor genes or activated a specific oncogene. The findings suggest a major role for the immune system in driving tumor evolution across multiple types of cancer. —YN

multidisciplinary sciences